Patent ID: 11897959
Assignee: BIOATLA, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 6:
7. The antibody or antibody fragment of claim 1, wherein the antibody or antibody fragment has a ratio of binding affinity to the Axl protein at a value of a condition in a tumor microenvironment and a binding affinity to the Axl protein at a different value of the same condition in a non-tumor microenvironment of at least about 2:1, at least about 3:1, at least about 4:1, at least about 5:1, at least about 6:1, at least about 7:1, at least about 8:1, at least about 9:1, at least about 10:1, at least about 20:1, at least about 30:1, at least about 50:1, at least about 70:1, or at least about 100:1.